NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)
NT trends in ecstasy and related drug markets; Reports; PublicationNT
2011
Made available via the Publications (Legal Deposit) Act 2004 (NT).
Date:2011; Australian drug trends series No. 80
English
Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals
National Drug and Alcohol Research Centre, University of New South Wales
Sydney (N.S.W)
9780733430206
Check within Publication or with content Publisher.
https://hdl.handle.net/10070/242182
https://hdl.handle.net/10070/610318
67 6.2.4 Cannabis Closed treatment episodes for cannabis increased slightly in 2010/11 (Figure 40) and continued to remain by far the most common reason for presentation at treatment. Figure 40: Number of episodes commenced in NT AODTS where cannabis was the principal or other drug of concern, 2001/02-2010/11 Source: NT AODP 6.2.5 Other drugs In 2010/11 there was an increase in closed episodes where morphine was the principal or other drug of concern. Consistent with the high level of morphine use in the NT, closed episodes where morphine was the principal or other drug of concern represented the second most common reason (after cannabis) for presentation at treatment (Figure 41). Figure 41: Number of episodes commenced in NT AODTS where morphine was the principal or other drug of concern, 2001/02-2010/11 Source: NT AODP The number of closed episodes for treatment where ecstasy was the principal or other drug of concern continued to decline in 2010/11 (Figure 42).